The use of desmopressin in open-heart surgery

Haemophilia

Volumn 14, Issue SUPPL. 1, 2008, Pages 40-47

  Cattaneo, Marco ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Bleeding; Blood transfusion; Desmopressin; Open heart surgery; Platelet function disorders

Indexed keywords

ACETYLSALICYLIC ACID; AMINOCAPROIC ACID; ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; APROTININ; BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; HEPARIN; HIRUDIN; PLACEBO; STREPTOKINASE; TICLOPIDINE; TRANEXAMIC ACID; VON WILLEBRAND FACTOR;

ARTERY THROMBOSIS; BLEEDING DISORDER; BLEEDING TIME; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; CHRONIC LIVER DISEASE; CLINICAL TRIAL; CRYOPRECIPITATE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG INFUSION; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG USE; FLUSHING; HEART DISEASE; HEART INFARCTION; HEART RATE; HEMOPHILIA A; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; HYPONATREMIA; NONHUMAN; OPEN HEART SURGERY; PATHOGENESIS; POSTOPERATIVE HEMORRHAGE; PREDICTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SECRETION; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SIDE EFFECT; SURGICAL RISK; SYMPTOM; THROMBOCYTE DISORDER; THROMBOCYTOPENIA; TOOTH EXTRACTION; VON WILLEBRAND DISEASE; WATER INTOXICATION; WATER RETENTION;

BLOOD LOSS, SURGICAL; BLOOD PLATELET DISORDERS; CARDIAC SURGICAL PROCEDURES; DEAMINO ARGININE VASOPRESSIN; HEMOSTATICS; HUMANS; PERIOPERATIVE CARE;

EID: 37449034020     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2007.01608.x     Document Type: Review

References (76)

1. Mannucci PM. Desmopressin: A non transfusional agent. Annu Rev Med 1990; 41: 55-64.
2. Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: The first 20 years. Blood 1997; 90: 2515-21.
3. Mannucci PM, Ruggeri ZM, Pareti FI, Capitanio A. 1-deamino-8-D-arginine vasopressin: A new pharmacological approach to the management of haemophilia and von Willebrand's diseases. Lancet 1977; 1: 869-72.
4. Cattaneo M, Mannucci PM. Desmopressin. In: Michelson AD, ed. Platelets. San Diego, CA: Academic Press, 2002: 855-66.
5. Mannucci PM, Remuzzi G, Pusineri F et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 1983; 308: 8-12.
6. Viganò GL, Mannucci PM, Lattuada A, Harris A, Remuzzi G. Subcutaneous desmopressin (DDAVP) shortens the bleeding time in uremia. Am J Hematol 1989; 31: 32-5.
7. Shapiro MD, Kelleher SP. Intranasal deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. Am J Nephrol 1984; 4: 260-1.
8. Rydzewski A, Rowinski M, Mysliwiec M. Shortening of bleeding time after intranasal administration of 1-deamino-8-D-arginine vasopressin to patients with chronic uremia. Folia Haematol Int Mag Klin Morphol Blutforsch 1986; 113: 823-30.
9. Mannucci PM, Vicente V, Vianello L et al. Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time. Blood 1986; 67: 1148-53.
10. Burroughs AK, Matthews K, Qadiri M et al. Desmopressin and bleeding time in patients with cirrhosis. Br J Med 1985; 291: 1377-81.
11. Lopez P, Otaso JC, Alvarez D et al. Hemostatic and hemodynamic effects of vasopressin analogue DDAVP in patients with cirrhosis. Acta Gastroenterol Latinoam 1997; 27: 59-62.
12. Cattaneo M, Tenconi PM, Alberca I, Vicente Garcia V, Mannucci PM. Subcutaneous desmopressin (DDAVP) shortens the prolonged bleeding time in patients with liver cirrhosis. Thromb Haemost 1990; 64: 358-60.
13. Parker RI, Grewal RP, McKeown LP, Barton NW. Effect of platelet count on the DDAVP-induced shortening of the bleeding time in thrombocytopenic Gaucher's patients. Am J Pediatr Hematol Oncol 1992; 14: 39-43.
14. Castaman G, Bona ED, Schiavotto C, Trentin L, D'Emilio A, Rodeghiero F. Pilot study on the safety and efficacy of desmopressin for the treatment or prevention of bleeding in patients with hematologic malignancies. Haematologica 1997; 82: 584-7.
15. Kobrinsky NL, Israels ED, Gerrard JM et al. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders. Lancet 1984; 1: 1145-8.
16. Cattaneo M, Lombardi R, Bettega D, Lecchi A, Mannucci PM. Shear-induced platelet aggregation is potentiated by desmopressin and inhibited by ticlopidine. Arterioscler Thromb 1993; 13: 393-7.
17. Schulman S, Johnsson H. Heparin, DDAVP and the bleeding time. Thromb Hemost 1991; 65: 242-4.
18. Johnstone MT, Andrews T, Ware JA et al. Bleeding time prolongation with streptokinase and its reduction with 1-deamino-8-D-arginine vasopressin. Circulation 1990; 82: 2142-51.
19. Bove CM, Casey B, Marder VJ. DDAVP reduces bleeding during continued hirudin administration in the rabbit. Thromb Haemost 1996; 75: 471-5.
20. Reiter RA, Mayr F, Blazicek H et al. Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. Blood 2003; 102: 4594-9.
21. Nielsen HJ. Detrimental effects of perioperative blood transfusions. Br J Surg 1995; 82: 582-7.
22. Vamvakas EC. Possible mechanisms of allogenic blood transfusion-associated postoperative infection. Transfus Med Rev 2002; 16: 144-60.
23. Goodnough LT, Despotis GJ. Transfusion medicine: Support of patients undergoing cardiac surgery. Am J Cardiovasc Drugs 2001; 1: 337-51.
24. Woosman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990; 76: 1680-97.
25. Cattaneo M, Harris AS, Stromberg U, Mannucci PM. The effect of desmopressin on reducing blood loss in cardiac surgery - a meta-analysis of double-blind, placebo-controlled trials. Thromb Haemost 1995; 74: 1064-70.
26. Salzman EW, Weinstein MJ, Weintraub RM et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial. N Engl J Med 1986; 314: 1402-6.
27. Rocha E, Llorens R, Paramo JA, Arcas R, Cuesta B, Trenor AM. Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass? Circulation 1988; 77: 1319-23.
28. Hackmann T, Gascoyne RD, Naiman SC et al. A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. N Engl J Med 1989; 321: 1437-43.
29. Seear MD, Wadsworth LD, Rogers PC, Sheps S, Ashmore PG. The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. J Thorac Cardiovasc Surg 1989; 98: 217-19.
30. Lazenby WD, Russo I, Zadeh BJ et al. Treatment with desmopressin acetate in routine coronary artery bypass surgery to improve postoperative hemostasis. Circulation 1990; 82: IV413-19.
31. Andersson TL, Solem JO, Tengborn L, Vinge E. Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation. Circulation 1990; 81: 872-8.
32. Hedderich GS, Petsikas DJ, Cooper BA et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: A prospective randomized clinical trial. Can J Surg 1990; 33: 33-6.
33. Reich DL, Hammerschlag BC, Rand JH et al. Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures. J Cardiothorac Vasc Anesth 1991; 5: 142-5.
34. Horrow JC, van Riper DF, Strong MD, Brodsky I, Parmet JL. Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation 1991; 84: 2063-70.
35. Gratz I, Koehler J, Olsen D et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. J Thorac Cardiovasc Surg 1992; 104: 1417-22.
36. de Prost D, Barbier-Boehm G, Hazebroucq J et al. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thromb Haemost 1992; 68: 106-10.
37. Ansell J, Klassen V, Lew R et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double-blind study. J Thorac Cardiovasc Surg 1992; 104: 117-23.
38. Mongan PD, Hosking MP. The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology 1992; 77: 38-46.
39. Marquez J, Koehler S, Strelec SR et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: A prospective, blinded, randomized study. J Cardiothorac Vasc Anesth 1992; 6: 674-6.
40. Dilthey G, Dietrich W, Spannagl M, Richter JA. Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. J Cardiothorac Vasc Anesth 1993; 7: 425-30.
41. Reynolds LM, Nicolson SC, Jobes DR et al. Desmopressin does not decrease bleeding after cardiac operation in young children. J Thorac Cardiovasc Surg 1993; 106: 954-8.
42. Rocha E, Hidalgo F, Llorens R, Melero JM, Arroyo JL, Paramo JA. Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation 1994; 90: 921-7.
43. Sheridan DP, Card RT, Pinilla JC et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic-acid-induced platelet dysfunction. Can J Surg 1994; 37: 33-6.
44. Temeck BK, Bachenheimer LC, Katz NM, Coughlin SS, Wallace RB. Desmopressin acetate in cardiac surgery: A double-blind, randomized study. South Med J 1994; 87: 611-15.
45. Casas JI, Zuazu-Jausoro I, Mateo J et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double-blind placebo-controlled study. J Thorac Cardiovasc Surg 1995; 110: 1107-17.
46. Despotis GJ, Levine V, Saleem R, Spitznagel E, Joist JH. Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: A randomised controlled trial. Lancet 1999; 354: 106-10.
47. Oliver WC Jr, Santrach PJ, Danielson GK, Nuttall GA, Schroeder DR, Ereth MH. Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Ann Thorac Surg 2000; 70: 1923-30.
48. Goodnough LT, Johnston MFM, Toy PTCY. The variability of transfusion practice in coronary artery bypass surgery. JAMA 1991; 265: 86-90.
49. Fremes SE, Wong BI, Lee E et al. Meta-analysis of prophylactic drug treatment in the prevention of postoperative bleeding. Ann Thorac Surg 1994; 58: 1580-8.
50. Levi M, Cromheecke ME, de Jonge E et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints. Lancet 1999; 354: 1940-7.
51. Weinstein M, Ware JA, Troll J, Salzman E. Changes in von Willebrand factor during cardiac surgery: Effect of desmopressin acetate. Blood 1988; 71: 1648-55.
52. Sakariassen KS, Cattaneo M, van den Berg A, Ruggeri ZM, Mannucci PM, Sixma JJ. DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium. Blood 1984; 64: 229-36.
53. Spiess BD, Tuman KJ, McCarthy RJ, DeLaria GA, Schillo R, Ivankovich AD. Thromboelastography as an indicator of postcardiopulmonary bypass coagulopathies. J Clin Monit 1987; 3: 25-30.
54. Poston R, Gu J, Manchio J et al. Platelet function tests predict bleeding and thrombotic events after off-pump coronary bypass grafting. Eur J Cardiothorac Surg 2005; 27: 584-91.
55. Cammerer U, Dietrich W, Rampf T, Braun SL, Richter JA. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 2003; 96: 51-7.
56. Despotis GJ, Joist JH, Goodnough LT. Monitoring of hemostasis in cardiac surgical patients: Impact of point-of-care testing on blood loss and transfusion outcomes. Clin Chem 1997; 43: 1684-96.
57. Morawski W, Sanak M, Cisowski M et al. Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: Role of aspirin and platelet glycoprotein IIIa polymorphism. J Thorac Cardiovasc Surg 2005; 130: 791-6.
58. Goldman S, Copeland J, Moritz T et al. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy. Circulation 1988; 77: 1324-32.
59. Ferraris VA, Ferraris SP, Lough FC, Berry W. Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grfting. Ann Thorac Surg 1988; 45: 71-4.
60. Pleym H, Stenseth R, Wahba A et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesth Analg 2004; 98: 578-84.
61. Kobrinsky NL, Letts RM, Patel LR et al. 1-Desamino-8-D-arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double-blinded, controlled trial. Ann Intern Med 1987; 107: 446-50.
62. Guay J, Rainberg C, Poitras B et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesth Analg 1992; 75: 405-10.
63. Theroux MC, Corddry DH, Tietz AE, Miller F, Peoples JD, Kettrick RG. A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: A randomized, controlled, double-blinded study. Anesthesiology 1997; 87: 260-7.
64. Alanay A, Acaroglu E, Ozdemir O, Ercelen O, Bulutcu E, Surat A. Effects of deamino-8-D-arginin vasopressin on blood loss and coagulation factors in scoliosis surgery. A double-blind randomized clinical trial. Spine 1999; 24: 877-82.
65. Flordal PA, Ljungstrom KG, Ekman B, Neander G. Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthop Scand 1992; 63: 381-5.
66. Schott U, Sollen C, Axelsson K, Rugarn P, Allvin I. Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiol Scand 1995; 39: 592-8.
67. Karnezis TA, Stulberg SD, Wixson RL, Reilly P. The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double-blind randomized trial. J Bone Joint Surg Am 1994; 76: 1545-1550.
68. Smith TJ, Gill JC, Ambruso DR, Hathaway WE. Hyponatremia and seizures in young children given DDAVP. Am J Hematol 1989; 31: 199-202.
69. Bertholini DM, Butler CS. Severe hyponatraemia secondary to desmopressin therapy in von Willebrand's disease. Anaesth Intensive Care 2000; 28: 199-201.
70. Mannucci PM, Carlsson S, Harris AS. Desmopressin, surgery and thrombosis. Thromb Haemost 1994; 71: 154-155.
71. Takeuchi M, Naguza H, Kanedu T. DDAVP and epinephrine induce changes in the localization of von Willebrand factor antigen in endothelial cells of human oral mucosa. Blood 1988; 72: 850-4.
72. Pareti FI, Cattaneo M, Carpinelli L et al. Evaluation of the abnormal platelet function in von Willebrand disease by the blood filtration test. Thromb Haemost 1996; 76: 460-8.
73. Cattaneo M, Federici AB, Lecchi A et al. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease. Thromb Haemost 1999; 82: 35-39.
74. Cattaneo M, Zighetti ML, Lombardi R, Mannucci PM. Role of ADP in platelet aggregation at high shear: Studies in a patient with congenital defect of platelet responses to ADP. Br J Haematol 1994; 88: 826-9.
75. Cattaneo M, Pareti FI, Zighetti M, Lecchi A, Lombardi R, Mannucci PM. Platelet aggregation at high shear is impaired in patients with congenital defects of platelet secretion and is corrected by DDAVP: correlation with the bleeding time. J Lab Clin Med 1995; 125: 540-7.
76. Cattaneo M, Moia M, Delle Valle P, Castellana P, Mannucci PM. DDAVP shortens the prolonged bleeding times of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factor. Blood 1989; 74: 1972-5.